Alcon Inc. (ALC) Stock Analysis
Recovery setup
Healthcare · Medical Instruments & Supplies
Sell if holding. Multiple concerning factors at $67.90: Consecutive earnings misses (2); Weak growth.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and... Read more
Sell if holding. Multiple concerning factors at $67.90: Consecutive earnings misses (2); Weak growth. Chart setup: Death cross but MACD improving, RSI 57. Score 5.0/10, moderate confidence.
Passes 8/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 62d clear, semi cycle peak clear, materials cycle peak clear). Suitability: moderate.
Recent developments
updated 2026-06-10Recent Developments — Alcon Inc.
Latest news
- NEWS Is Alcon Inc (ALC) a Bargain After 3.4% Drop? GF Value Says Unde - GuruFocus — GuruFocus neutral
- NEWS ALC (Alcon) drops 3.44% after posting narrow Q4 2025 EPS miss versus analyst estimates. - Hot Momentum Watchlist - Newse — Newser negative
- NEWS Alcon Inc. (ALC) Stock Falls on Q1 2026 Earnings - Quiver Quantitative — Quiver Quantitative negative
- NEWS Alcon Inc. Elects R. Scott Herren as New Independent Member of the Board - marketscreener.com — marketscreener.com positive
- NEWS Lensar stock slumps after hours on ending merger deal with Alcon over FTC pushback - MSN — MSN negative
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Analyst Consensus
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Multiple concerning factors at $67.90: Consecutive earnings misses (2); Weak growth. Chart setup: Death cross but MACD improving, RSI 57. Prior stop was $65.12. Score 5.0/10, moderate confidence.
Take-profit target: $79.67 (+17.3% upside). Prior stop was $65.12. Stop-loss: $65.12.
Consecutive earnings misses (2); Weak growth; Below 200-MA, MA slope -3.8%/30d (confirmed downtrend).
Alcon Inc. trades at a P/E of 39.6 (forward 16.7). TrendMatrix value score: 5.8/10. Verdict: Sell.
18 analysts cover ALC with a consensus score of 4.0/5. Average price target: $89.
What does Alcon Inc. do?Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates...
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.